Antibody glycosylation as a potential biomarker for chronic inflammatory autoimmune diseases
Glycosylation of immunoglobulins (Ig) is known to influence their effector functions in physiological and pathological conditions. Changes in the glycosylation pattern of immunoglobulin G and autoantibodies in various inflammatory autoimmune diseases have been studied for many years. However, despit...
Main Authors: | Jasmin Knopf, Mona HC Biermann, Luis E Muñoz, Martin Herrmann |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2016-12-01
|
Series: | AIMS Genetics |
Subjects: | |
Online Access: | http://www.aimspress.com/Genetics/article/1140/fulltext.html |
Similar Items
-
Abnormal B cell glycosylation in autoimmunity: A new potential treatment strategy
by: Marie Morel, et al.
Published: (2022-08-01) -
Editorial: Targeting Phosphorylation and Glycosylation of Membrane-Bound Oncogenic Drivers, Receptors and Adhesion Molecules to Control Constitutive Proliferation of Human Carcinoma Cells
by: Muhammad R. M. Hussain, et al.
Published: (2018-07-01) -
The Role of Glycosylation in Melanoma Progression
by: Chiara De Vellis, et al.
Published: (2021-08-01) -
Glycosylation in Renal Cell Carcinoma: Mechanisms and Clinical Implications
by: Xinqing Zhu, et al.
Published: (2022-08-01) -
CD44 Glycosylation as a Therapeutic Target in Oncology
by: Chengcheng Liao, et al.
Published: (2022-07-01)